Dicerna
Dicerna is a Massachusetts-based biotechnology company that develops and commercializes RNAi therapies for the treatment of cardiometabolic and complement-mediated diseases.
Business Model:
Revenue: $192.8M
Employees: 201-500
Rankings
Industries / Tags:
Detailed Dicerna Information
Dicerna was acquired by
Novo Nordisk.
The acquisition happend on 2021-11-18.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 75 Hayden Avenue
City: Lexington
State: MA
Zip: 02421
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$100M
Raised Total:$271M
Social
Metrics
3,125,378Website Global Rank
5,278Website Monthly Traffic
Twitter Followers
Description
Dicerna is a Massachusetts-based biotechnology company that develops and commercializes RNAi therapies for the treatment of cardiometabolic and complement-mediated diseases.
Contact Phone:
+16176218097
Contact Email:
Dicerna went public on 1/31/2014 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
1/31/2014
IPO Valuation:
$188M
Ticker Symbol:
DRNA
IPO Price:
$15/share
Amount Raised:
$90M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
